Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...
Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.
Continuous glucose monitors — tiny sensors once reserved for people with diabetes — are now appearing on the arms of runners, nutrition enthusiasts, and wellness influencers. As the devices have ...
Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...
Abstract: This paper presents the scientific outcomes of the 2018 Data Fusion Contest organized by the Image Analysis and Data Fusion Technical Committee of the IEEE Geoscience and Remote Sensing ...
Stifel projected that the 15-day sensor could enhance DexCom’s gross margin in 2026, potentially contributing to year-over-year EBITDA margin expansion. The firm acknowledged certain risks, including ...
Investing.com - Stifel resumed coverage of DexCom (NASDAQ:DXCM) with a Buy rating and set a price target of $85.00, according to a research note published Monday. The company, currently trading at $68 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback